Abstract
Antimicrobial resistance (AMR) poses an important global health challenge, including insufficient investment in research and development. This study quantifies the required fair share" contributions from the G7+EU27 countries for an effective set of pull incentives for antibacterial research and development."
Key Data
-
Publication Date08 September 2025
-
Primary AuthorMatt McEnany
-
Sourcesciencedirect.com
-
LanguageEnglish
Click below to visit original source: